La Jolla Pharmaceutical Company
Hedge Funds Holdings
Last updated:
La Jolla Pharmaceutical Company‘s stocks are currently a part of 43 hedge funds’ portfolios, which represents 48.26% of the total amount of its stocks outstanding. This makes up a total of 16.49M shares of La Jolla Pharmaceutical Company. Compared to the previous quarter, the number fell by -1.44% or -241.37K shares fewer. As for the holding position changes, 13.95% (6) of current hedge fund investors increased the number of shares held, 51.16% (22) of current holders sold a part of the shares held, and 9.3% (4) closed the holdings completely. 5 hedge funds are new holders of La Jolla Pharmaceutical Company stock in Q1 2022, it is 11.63% of total holders.
Hedge funds holding La Jolla Pharmaceutical Company (Q2 2017 – Q1 2022)
| Q2 2017 | 83 |
|---|---|
| Q3 2017 | 95 |
| Q4 2017 | 93 |
| Q1 2018 | 100 |
| Q2 2018 | 94 |
| Q3 2018 | 76 |
| Q4 2018 | 81 |
| Q1 2019 | 80 |
| Q2 2019 | 81 |
| Q3 2019 | 74 |
| Q4 2019 | 76 |
| Q1 2020 | 72 |
| Q2 2020 | 73 |
| Q3 2020 | 63 |
| Q4 2020 | 62 |
| Q1 2021 | 74 |
| Q2 2021 | 60 |
| Q3 2021 | 51 |
| Q4 2021 | 43 |
| Q1 2022 | 43 |
Hedge funds changes in La Jolla Pharmaceutical Company positions (Q2 2017 – Q1 2022)
| Q2 2017 | 16 | 46 | 14 | 24 | -17 |
|---|---|---|---|---|---|
| Q3 2017 | 24 | 29 | 26 | 10 | 6 |
| Q4 2017 | 17 | 37 | 27 | 19 | -7 |
| Q1 2018 | 22 | 34 | 25 | 14 | 5 |
| Q2 2018 | 14 | 39 | 25 | 20 | -4 |
| Q3 2018 | 7 | 36 | 18 | 25 | -10 |
| Q4 2018 | 17 | 24 | 24 | 13 | 3 |
| Q1 2019 | 21 | 22 | 18 | 22 | -3 |
| Q2 2019 | 20 | 25 | 25 | 17 | -6 |
| Q3 2019 | 9 | 27 | 17 | 15 | 6 |
| Q4 2019 | 19 | 23 | 20 | 16 | -2 |
| Q1 2020 | 14 | 20 | 24 | 14 | 0 |
| Q2 2020 | 17 | 25 | 17 | 17 | -3 |
| Q3 2020 | 5 | 16 | 25 | 15 | 2 |
| Q4 2020 | 6 | 19 | 20 | 9 | 8 |
| Q1 2021 | 17 | 16 | 22 | 5 | 14 |
| Q2 2021 | 9 | 11 | 30 | 22 | -12 |
| Q3 2021 | 6 | 9 | 21 | 15 | 0 |
| Q4 2021 | 6 | 13 | 15 | 15 | -6 |
| Q1 2022 | 5 | 6 | 22 | 4 | 6 |
Hedge funds changes in La Jolla Pharmaceutical Company stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 11,734,000 | 5,284,000 |
|---|---|---|
| Q3 2017 | 5,353,000 | 43,969,000 |
| Q4 2017 | 6,353,000 | 11,204,000 |
| Q1 2018 | 5,852,000 | 13,416,000 |
| Q2 2018 | 2,168,000 | 5,472,000 |
| Q3 2018 | 5,811,000 | 956,000 |
| Q4 2018 | 389,000 | 374,000 |
| Q1 2019 | 340,000 | 455,000 |
| Q2 2019 | 1,627,000 | 1,686,000 |
| Q3 2019 | 717,000 | 611,000 |
| Q4 2019 | 294,000 | 289,000 |
| Q1 2020 | 464,000 | 563,000 |
| Q2 2020 | 378,000 | 444,000 |
| Q3 2020 | 235,000 | 375,000 |
| Q4 2020 | 251,000 | 123,000 |
| Q1 2021 | 114,000 | 294,000 |
| Q2 2021 | 304,000 | 268,000 |
| Q3 2021 | 158,000 | 114,000 |
| Q4 2021 | 165,000 | 53,000 |
| Q1 2022 | 102,000 | 0 |